COSM -
Cosmos Holdings Inc. Common Stock
Day |
1m |
10m |
60m |
PreMarket |
Market |
AfterHours |
Gap |
1.15 0.07 (6.22%) |
--- |
0.0 (0.0%) |
0.0 (0.0%) |
-0.03 (-2.5%) |
0.12 (11.12%) |
-0.02 (-1.6%) |
-0.02 (-1.6%) |
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
Earnings & Ratios
- Basic EPS:
- -0.1
- Diluted EPS:
- -0.1
- Basic P/E:
- -12.202
- Diluted P/E:
- -12.202
- RSI(14) 1m:
- 66.67
- VWAP:
- 1.22
- RVol:
Events
Period |
Kind |
Movement |
Occurred At |
Related News
Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility
Oct 10, 2025 12:00
Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units
Oct 03, 2025 19:56
Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue
Sep 22, 2025 12:00
Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
Sep 11, 2025 12:00
Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
Aug 18, 2025 16:45
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000
Apr 30, 2025 16:50
Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.
Sep 16, 2024 12:30
Cosmos Health secures new pharma manufacturing deals - Investing.com
Jul 18, 2024 21:16
Cosmos Health subsidiary secures Australian CBD product deal By Investing.com - Investing.com
Jul 09, 2024 18:27
MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates
May 29, 2024 12:15